Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Total Current Liabilities (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Total Current Liabilities readings, the most recent being $1.7 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 4.19% to $1.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.7 million, a 4.19% decrease, with the full-year FY2025 number at $2.3 million, up 4.06% from a year prior.
  • Total Current Liabilities hit $1.7 million in Q1 2026 for Neuroone Medical Technologies, up from $1.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.1 million in Q3 2022 to a low of $810231.0 in Q1 2022.
  • Median Total Current Liabilities over the past 5 years was $1.6 million (2024), compared with a mean of $1.6 million.
  • Biggest five-year swings in Total Current Liabilities: soared 162.22% in 2022 and later tumbled 42.15% in 2023.
  • Neuroone Medical Technologies' Total Current Liabilities stood at $1.3 million in 2022, then rose by 3.63% to $1.4 million in 2023, then increased by 13.57% to $1.6 million in 2024, then decreased by 19.89% to $1.3 million in 2025, then surged by 34.25% to $1.7 million in 2026.
  • The last three reported values for Total Current Liabilities were $1.7 million (Q1 2026), $1.3 million (Q4 2025), and $2.3 million (Q3 2025) per Business Quant data.